Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study

Journal of Research in Medical Sciences

Volumn 22, Issue 1, 2017, Pages

  Ashtari, Fereshte ^a,b   Safaei, Ali ^a,b   Shaygannejad, Vahid ^a,b   Najafi, Mohammad Amin ^a,b   Vesal, Sahar ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Demographics; Devic s syndrome; Iran; Neuromyelitis optic

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; METHOTREXATE; MYCOPHENOLATE MOFETIL;

ADULT; ANTIBODY DETECTION; ARTICLE; CERVICAL SPINAL CORD INJURY; CERVICAL SPINE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IRAN; LOW DRUG DOSE; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; SPINAL CORD LESION;

EID: 85031314707     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: 10.4103/1735-1995.202142     Document Type: Article

References (20)

1. Jurynczyk M, Craner M, Palace J. Overlapping CNS inflammatory diseases: Differentiating features of NMO and MS. J Neurol Neurosurg Psychiatry 2015;86:20-5.
2. Wingerchuk D, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T, et al. Revised diagnostic criteria for neuromyelitis optica spectrum disorders (S63. 001). Neurology 2014;82(10 Supplement):S63. 001.
3. Etemadifar M, Nasr Z, Khalili B, Taherioun M, Vosoughi R. Epidemiology of neuromyelitis optica in the world: A systematic review and meta-analysis. Mult Scler Int 2015;2015:174720.
4. Nakajima H, Hosokawa T, Sugino M, Kimura F, Sugasawa J, Hanafusa T, et al. Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis. BMC Neurol 2010;10:45.
5. Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999;53:1107-14.
6. Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, et al. Pain in neuromyelitis optica – Prevalence, pathogenesis and therapy. Nat Rev Neurol 2014;10:529-36.
7. Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, et al. Brainstem manifestations in neuromyelitis optica: A multicenter study of 258 patients. Mult Scler 2014;20:843-7.
8. Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: A multicenter analysis. Arch Neurol 2012;69:1176-80.
9. Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, et al. Neuromyelitis optica in France: A multicenter study of 125 patients. Neurology 2010;74:736-42.
10. Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010;17:1019-32.
11. Sahraian MA, Radue EW, Minagar A. Neuromyelitis optica: Clinical manifestations and neuroimaging features. Neurol Clin 2013;31:139-52.
12. Bergamaschi R, Ghezzi A. Devic’s neuromyelitis optica: Clinical features and prognostic factors. Neurol Sci 2004;25 Suppl 4:S364-7.
13. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
14. Sahraian MA, Moinfar Z, Khorramnia S, Ebrahim MM. Relapsing neuromyelitis optica: Demographic and clinical features in Iranian patients. Eur J Neurol 2010;17:794-9.
15. Mandler RN. Neuromyelitis optica – Devic’s syndrome, update. Autoimmun Rev 2006;5:537-43.
16. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, de Almeida AM, Oliveira S, Basilio De Oliveira CA, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002;73:429-35.
17. O’Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, et al. Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996;60:382-7.
18. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: A consensus approach. Mult Scler 2008;14:1157-74.
19. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
20. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-7.